152 related articles for article (PubMed ID: 38142245)
1. Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.
Yamchi A; Rahimi M; Javan B; Abdollahi D; Salmanian M; Shahbazi M
Arch Microbiol; 2023 Dec; 206(1):37. PubMed ID: 38142245
[TBL] [Abstract][Full Text] [Related]
2. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
3. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
4. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
5.
Albuquerque RCMF; Brandão ABP; De Abreu ICME; Ferreira FG; Santos LB; Moreira LN; Taddei CR; Aimbire F; Cunha TS
Benef Microbes; 2019 Dec; 10(8):901-912. PubMed ID: 31965836
[TBL] [Abstract][Full Text] [Related]
6. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes.
Abreu ICME; Albuquerque RCMF; Brandão ABP; Barssotti L; de Souza LB; Ferreira FG; Oliveira LCG; Yokota R; Sparvoli LG; Dias DDS; Salgado MAC; Taddei C; De Angelis K; Casarini DE; Cunha TS
Life Sci; 2022 Jul; 301():120616. PubMed ID: 35533758
[TBL] [Abstract][Full Text] [Related]
8. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
9. Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach.
Durmusoglu D; Al'Abri I; Li Z; Islam Williams T; Collins LB; Martínez JL; Crook N
Microb Cell Fact; 2023 Jun; 22(1):109. PubMed ID: 37287064
[TBL] [Abstract][Full Text] [Related]
10. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
11.
Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
[No Abstract] [Full Text] [Related]
12. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
13. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.
Everard A; Matamoros S; Geurts L; Delzenne NM; Cani PD
mBio; 2014 Jun; 5(3):e01011-14. PubMed ID: 24917595
[TBL] [Abstract][Full Text] [Related]
15. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
16. Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia.
Wang BL; Zhang WJ; Zhao J; Wang FJ; Fan LQ; Wu YX; Hu ZB
J Sci Food Agric; 2011 Oct; 91(13):2443-8. PubMed ID: 21626510
[TBL] [Abstract][Full Text] [Related]
17. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
18. Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.
Khatri I; Tomar R; Ganesan K; Prasad GS; Subramanian S
Sci Rep; 2017 Mar; 7(1):371. PubMed ID: 28336969
[TBL] [Abstract][Full Text] [Related]
19. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
Abdollahi M; Zuki AB; Goh YM; Rezaeizadeh A; Noordin MM
Histol Histopathol; 2011 Jan; 26(1):13-21. PubMed ID: 21117023
[TBL] [Abstract][Full Text] [Related]
20. Preventive Effect of
Babaei F; Mirzababaei M; Dargahi L; Shahsavari Z; Nassiri-Asl M; Karima S
ACS Chem Neurosci; 2022 Nov; 13(22):3180-3187. PubMed ID: 36318666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
